2022. Selective Serotonin Reuptake Inhibitors Response and the Impact of CYP2C19 Metabolizer Status. Precision Medicine Communications. 2, 1 (Jun. 2022), 05–07. DOI:https://doi.org/10.55627/pmc.002.01.0097.